Sight Sciences Inc (SGHT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sight Sciences Inc (SGHT) has a cash flow conversion efficiency ratio of -0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.72 Million) by net assets ($64.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sight Sciences Inc (SGHT) total market value for the company's overall valuation and market capitalisation.
Sight Sciences Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Sight Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sight Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sight Sciences Inc ranked by their cash flow conversion efficiency. See Sight Sciences Inc (SGHT) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Los Andes Copper Limited
V:LA
|
0.003x |
|
Meter Instruments Co. Ltd
SHE:301006
|
0.029x |
|
Socep Constant
RO:SOCP
|
N/A |
|
Experian PLC
LSE:EXPN
|
0.251x |
|
Windsor Machines Limited
NSE:WINDMACHIN
|
-0.057x |
|
AGORA INC. SP.ADS/4 CL.A
F:9AG1
|
0.010x |
|
SungEel HiTech Co. Ltd.
KQ:365340
|
0.093x |
|
ABEONA THERAPEUT. DL-01
F:PCJ
|
-0.113x |
Annual Cash Flow Conversion Efficiency for Sight Sciences Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Sight Sciences Inc from 2018 to 2024. View SGHT live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $87.52 Million | $-22.35 Million | -0.255x | +34.94% |
| 2023-12-31 | $120.22 Million | $-47.18 Million | -0.392x | +17.29% |
| 2022-12-31 | $160.08 Million | $-75.97 Million | -0.475x | -109.65% |
| 2021-12-31 | $232.11 Million | $-52.54 Million | -0.226x | -162.51% |
| 2020-12-31 | $-88.85 Million | $-32.17 Million | 0.362x | -20.78% |
| 2019-12-31 | $-54.68 Million | $-25.00 Million | 0.457x | -8.54% |
| 2018-12-31 | $-28.96 Million | $-14.47 Million | 0.500x | -- |
About Sight Sciences Inc
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeo… Read more